EMA Considers Fast-Tracking Rhythm’s Insatiable Hunger & Obesity Disorders Drug

Setmelanotide, which is being developed to treat insatiable hunger and early-onset severe obesity in people with rare genetic disorders, was also recently submitted to the US regulator for approval.